CE SEC Filings
SEC filings for CE. Annual and quarterly reports, 8-K events, Form 4 insider filings and 13D/G stake disclosures.
| Form | Filed | Accession |
|---|---|---|
| 10-QAICelanese's MD&A reports modest sales growth and a swing to operating profit as last year's $1.5 billion impairment does not recur. | Nov 3, 2026 | 0001306830-26-000133EDGAR |
| 10-QAICelanese reports higher net sales and operating profit, helped by pricing and the Micromax sale. | Aug 5, 2026 | 0001306830-26-000117EDGAR |
| 10-QAICelanese reports a mixed quarter: operating profit rose on the Micromax divestiture gain and cost savings, but net sales fell and the Acetyl Chain segment weakened amid soft demand and oversupply. | May 6, 2026 | 0001306830-26-000096EDGAR |
SEC filings for companies related to CE
Never miss a CE filing.
Get an email when CE files its next 8-K, Form 4, 10-K or 10-Q with the SEC. Free, no account needed.
Free foreverNo account requiredOne-click unsubscribe
Source: SEC EDGAR.